Optimal Vitamin D Levels: What the Research Actually Says About the Ideal Range
"In range" isn't the same as optimal. A research-based look at the actual ideal vitamin D level, why the lab's reference range can be misleading, and how to read your own 25-hydroxyvitamin D result.
If you've ever gotten a vitamin D test back "in range" and still felt exhausted, achy, or like something was off — you're not imagining it. There's a gap between what labs call "normal" and what current research suggests is actually optimal for energy, immunity, bone density, cardiovascular health, and long-term disease prevention.
This post breaks down what the evidence actually says about optimal 25-hydroxyvitamin D levels, why clinical "sufficient" isn't the same as biologically optimal, and how to interpret your own number.
The quick answer
Most labs flag vitamin D as deficient below 20 ng/mL and sufficient above 30 ng/mL. But a growing body of dose-response research suggests the lowest risk for most disease outcomes sits between 30 and 50 ng/mL — and for cardiovascular, cancer, and all-cause mortality, some of the strongest benefits appear between 40 and 60 ng/mL.
If you want a single target: 40–60 ng/mL (100–150 nmol/L) is where the research consensus lands for healthy adults who want to move past "not deficient" into optimization territory.
The four reference ranges you'll see
Understanding your result requires understanding whose definition is being used:
- Deficient: Below 20 ng/mL (50 nmol/L). This is where rickets, osteomalacia, and clear-cut bone problems start. The 2024 Endocrine Society guideline flags below 12 ng/mL as severe deficiency.
- Insufficient: 20–30 ng/mL. Traditional medicine often calls this "low but not a problem." Newer evidence disagrees.
- Sufficient: 30+ ng/mL. What most labs and the 2011 Endocrine Society guideline call adequate. Sufficient ≠ optimal.
- Optimal (the research view): 40–60 ng/mL. Multiple meta-analyses of dose-response data point to this range as the sweet spot for reducing risk across cancer, cardiovascular disease, type 2 diabetes, and all-cause mortality.
Why "normal range" is misleading
Lab reference ranges are built from population averages. Given that roughly 35–42% of U.S. adults are vitamin D deficient — and another large chunk sit in the insufficient zone — the "normal" range in a lot of countries reflects a widely-deficient population, not a healthy one.
This is why you can get a result like 25 ng/mL and see no flag from your doctor, while functional medicine and longevity researchers would consider that inadequate for disease prevention. A test result in the 20s sits "technically within reference" but in the bottom third of the research-optimal range.
What the 2024 Endocrine Society guideline actually said
The 2024 Endocrine Society guideline on vitamin D for disease prevention made headlines for pushing back against routine vitamin D testing and supplementation in healthy adults under 75. That got reported as "vitamin D doesn't matter" — which is not what the guideline said.
What it actually said:
- For healthy adults under 50, there isn't enough randomized trial evidence to recommend empiric supplementation beyond the RDA (600 IU/day).
- Routine testing in asymptomatic healthy adults without risk factors isn't cost-effective at the population level.
- Specific populations — children, pregnant women, adults over 75, and people with high-risk prediabetes — do appear to benefit from supplementation.
Meanwhile, observational and dose-response data continues to suggest benefits above 30–40 ng/mL. The 2024 guideline is a public health recommendation for the general population. If you're specifically trying to optimize your health based on your own data — which is the entire point of tracking biomarkers — those two framings diverge.
The evidence for the 40–60 ng/mL target
Here's what the research actually shows at different levels:
Bone health. Risk of fracture and falls drops sharply above 30 ng/mL and plateaus around 40–50 ng/mL in older adults. All-cause mortality. Dose-response meta-analyses consistently show the lowest mortality risk between roughly 40 and 75 ng/mL. Below 30 ng/mL, mortality risk climbs meaningfully. Above 80 ng/mL, the curve flattens and may bend upward in some analyses. Cancer risk. A pooled analysis of a randomized trial and prospective cohort data suggested 25(OH)D levels at or above 40 ng/mL were associated with a substantially lower cancer risk compared to levels below 20 ng/mL. Cardiovascular disease. A 2025 American Heart Association Scientific Sessions presentation on the TARGET-D trial reported that adults with a prior heart attack who achieved blood levels of 40–80 ng/mL through personalized dosing had a 52% reduction in repeat heart attack risk compared to usual care. More than half of the treatment group needed doses above 5,000 IU/day to hit target. Type 2 diabetes prevention. In adults with high-risk prediabetes, vitamin D supplementation reduced progression to diabetes by about 10% in pooled data, with stronger effects when 25(OH)D levels exceeded 50 ng/mL. Respiratory infections. Vitamin D supplementation shows clearer protective effects in already-deficient populations, with diminishing returns once levels exceed ~30 ng/mL.The pattern is consistent: below 20 ng/mL is clearly problematic, 20–30 is suboptimal, 30–40 is adequate for bones but leaves other outcomes on the table, and 40–60 appears to be where the curve flattens favorably for most outcomes.
Does going above 60 ng/mL give you more?
Evidence for meaningful additional benefit above 60 ng/mL weakens quickly. Some cancer researchers have argued for targets as high as 55–80 ng/mL specifically for cancer prevention, but that's a minority position.
Above 100 ng/mL you're edging toward potential issues — not from vitamin D directly, but from secondary hypercalcemia (elevated blood calcium). U.S. Food and Nutrition Board guidance suggests concentrations above 125 nmol/L (50 ng/mL) may be associated with adverse effects in some people, though true toxicity typically requires sustained levels above 150 ng/mL.
The practical target: 40–60 ng/mL gives you the research benefits without pushing into margins of concern.
How to read your own test result
If your 25-OH vitamin D test came back:
- Below 20 ng/mL: Deficient. This warrants attention regardless of symptoms. See the dosing guide for raising vitamin D.
- 20–29 ng/mL: Insufficient. Your lab might call this "normal" or just flag the lower bound. From a research-based optimization perspective, this is below where most benefits start.
- 30–39 ng/mL: Adequate. You're meeting the traditional sufficiency threshold, but you have room to move into the optimal range.
- 40–60 ng/mL: Optimal. This is the sweet spot backed by most of the dose-response research.
- 60–80 ng/mL: Probably fine, possibly extra benefit for specific high-risk populations (like post-heart-attack patients), but diminishing returns for most people.
- Above 80 ng/mL: Worth reviewing your supplementation. Not harmful at these levels, but you can likely back off without losing the benefits.
The units confusion problem
You'll see vitamin D results in two units depending on where you tested:
- ng/mL (nanograms per milliliter) — U.S. default
- nmol/L (nanomoles per liter) — European default
If your result says "75" and your doctor says you're fine, check the units first — 75 nmol/L is barely sufficient, not optimal. 75 ng/mL is well into the optimal range.
25-OH-D vs 1,25-dihydroxyvitamin D
When you order "a vitamin D test," make sure you're getting 25-hydroxyvitamin D (25-OH-D), the storage form. This is the marker that reflects your overall vitamin D status.
The related marker, 1,25-dihydroxyvitamin D (the active hormone form), measures something different — active conversion at the kidney, which is regulated by parathyroid hormone and typically stays in a narrow range even when your storage is low. It's not the right test for assessing your vitamin D status and gets ordered incorrectly all the time. Here's how the two differ.
The takeaway
"In range" is not the same as optimal. If your goal is disease prevention, energy, and longevity — not just avoiding rickets — aim for 40–60 ng/mL of 25-hydroxyvitamin D, test at least annually, and adjust dosing based on where you actually land.
If you don't know your number, you're guessing. And if your doctor didn't run it last time, it's available through direct-to-consumer labs for $30–50.
Once you have your result, VitaDash tracks your vitamin D alongside 40+ other biomarkers across every blood test you upload — so you can see exactly how your dosing changes move your levels over time, and whether you're actually in the optimal range.
Related reading Medical disclaimer: This is for informational purposes only and not medical advice. Consult a healthcare provider before making changes to your supplementation.